ARQT - Arcutis Biotherapeutics GAAP EPS of -$1.31 beats by $0.12
- Arcutis Biotherapeutics press release ( NASDAQ: ARQT ): Q2 GAAP EPS of -$1.31 beats by $0.12 .
- Cash, cash equivalents, restricted cash, and marketable securities were $283.4 million as of June 30, 2022, compared to $388.6 million as of December 31, 2021.
For further details see:
Arcutis Biotherapeutics GAAP EPS of -$1.31 beats by $0.12